Honor the resident's right to request, refuse, and/or discontinue treatment, to participate in or refuse to participate in experimental research, and to formulate an advance directive.
F578 in District of Columbia. Pick another state for the same tag.
Against expectation — 2025
District of Columbia cites F578 less often than its own record predicts
Versus expected share0.84×
0.84 times the national share — cited less often here than elsewhere.
Share of District of Columbia citations0.80%
Of every deficiency written in District of Columbia in 2025, this is the portion that was F578.
District of Columbia0.80%
National0.95%
Share of all citations that were F578.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What District of Columbia surveyors wrote
F578 findings written in District of Columbia, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
E · No harm, potential for more than minimal, patternMay 5, 2025
Based on record review and staff interview, five (5) of 49 residents sampled, facility staff failed to have documented evidence that they provided information to the residents and/or their representatives (RP) regarding their right to formulate or refuse an advanced directive. Residents #87, #56, #91, #74, and #73.
The findings included:
Review of the facility's Advanced Directives policy dated 05/24/24 documented:
- Upon admission, the resident will be provided with written information concerning the right to refuse or accept medical or surgical treatment and to formulate an advanced directive if he or she chooses to do so. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction